Hennion & Walsh Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.18M | Buy |
|
|||||
|
2025
Q2 | $859K | Buy |
|
|||||
|
2025
Q1 | $1.22M | Buy |
|
|||||
|
2024
Q4 | $2.49M | Sell |
|
|||||
|
2024
Q3 | $3.3M | Sell |
|
|||||
|
2024
Q2 | $2.95M | Sell |
|
|||||
|
2024
Q1 | $6.04M | Buy |
|
|||||
|
2023
Q4 | $2.33M | Buy |
|
|||||
|
2023
Q3 | $821K | Sell |
|
|||||
|
2023
Q2 | $1.28M | Buy |
|
|||||
|
2023
Q1 | $1.1M | Buy |
|
|||||
|
2022
Q4 | $1.08M | Buy |
|
|||||
|
2022
Q3 | $884K | Buy |
|
|||||
|
2022
Q2 | $928K | Buy |
|
|||||
|
2022
Q1 | $811K | Buy |
|
|||||
|
2021
Q4 | $563K | Buy |
|